SEI Investments’s Moderna MRNA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$18.5M Buy
95,971
+11,191
+13% +$1.21M 0.02% 808
2026
Q2
$5.94M Sell
84,780
-44,615
-34% -$2.31M 0.01% 1408
2026
Q1
$6.57M Buy
129,395
+55,939
+76% +$2.61M 0.01% 1368
2025
Q4
$2.17M Sell
73,456
-3,882
-5% -$105K ﹤0.01% 1816
2025
Q3
$2M Sell
77,338
-23,499
-23% -$656K ﹤0.01% 1696
2025
Q2
$2.78M Buy
100,837
+32,527
+48% +$857K ﹤0.01% 1516
2025
Q1
$1.94M Buy
68,310
+6,451
+10% +$229K ﹤0.01% 1647
2024
Q4
$2.57M Sell
61,859
-8,835
-12% -$422K ﹤0.01% 1586
2024
Q3
$4.72M Sell
70,694
-6,063
-8% -$557K 0.01% 1314
2024
Q2
$9.12M Sell
76,757
-8,153
-10% -$1.03M 0.01% 965
2024
Q1
$9.05M Buy
84,910
+11,977
+16% +$1.21M 0.01% 948
2023
Q4
$7.25M Sell
72,933
-1,814
-2% -$153K 0.01% 1020
2023
Q3
$7.72M Sell
74,747
-10,419
-12% -$1.16M 0.01% 968
2023
Q2
$10.3M Buy
85,166
+13,502
+19% +$1.8M 0.02% 854
2023
Q1
$11M Buy
71,664
+25,635
+56% +$4.23M 0.02% 784
2022
Q4
$8.27M Sell
46,029
-6,508
-12% -$1.06M 0.02% 813
2022
Q3
$6.21M Sell
52,537
-21,407
-29% -$3.25M 0.01% 994
2022
Q2
$10.5M Buy
73,944
+15,784
+27% +$2.26M 0.02% 757
2022
Q1
$10M Buy
58,160
+17,031
+41% +$2.87M 0.02% 777
2021
Q4
$10.5M Sell
41,129
-5,344
-11% -$1.56M 0.02% 771
2021
Q3
$17.8M Sell
46,473
-17,120
-27% -$6.31M 0.04% 496
2021
Q2
$14.9M Buy
63,593
+8,890
+16% +$1.59M 0.03% 540
2021
Q1
$6.98M Buy
54,703
+2,723
+5% +$395K 0.02% 852
2020
Q4
$5.43M Buy
+51,980
New +$5.26M 0.01% 935
2019
Q2
– Sell
-1,872
Closed -$21K – 2632
2019
Q1
$21K Buy
1,872
+1,082
+137% +$20.1K ﹤0.01% 2740
2018
Q4
$1K Buy
+790
New +$1K ﹤0.01% 2626

Other funds holding MRNA

SEI Investments's MRNA Position: Q3 2026 in Review

SEI Investments increased its Moderna (MRNA) stake by 13% in Q3 2026, buying an estimated $1.21M and bringing the position to 95,971 shares worth $18.5M. The position accounts for 0.02% of the portfolio, ranked #808.

SEI Investments first reported a position in MRNA in Q4 2018 and has held it in 26 quarters since. 1,053 funds tracked by Wall St. Rank hold MRNA as of Q3 2026.

  • SEI Investments held 95,971 shares of Moderna worth $18.5M as of Q3 2026.
  • SEI Investments bought 11,191 Moderna shares in Q3 2026, an estimated $1.21M.
  • Moderna made up 0.02% of SEI Investments's portfolio in Q3 2026, its #808 holding.
  • SEI Investments first reported a position in Moderna in Q4 2018 and has held it in 26 quarters since.
  • 1,053 funds tracked by Wall St. Rank held Moderna as of Q3 2026.

Based on SEI Investments's 13F filing for Q3 2026, filed 10 Nov 2026.